Literature DB >> 20221674

Increased affinity to canalicular P-gp via formation of lipophilic ion-pair complexes with endogenous bile salts is associated with mw threshold in hepatobiliary excretion of quaternary ammonium compounds.

Im-Sook Song1, Min-Koo Choi, Qing-Ri Jin, Won-Sik Shim, Chang-Koo Shim.   

Abstract

OBJECTIVES: We intended to elucidate the mechanism of the molecular weight (Mw) threshold (i.e., 200 +/- 50) for appreciable hepatobiliary excretion of quaternary ammonium compounds (QACs) in rats.
METHODS: We measured the effect of ion-pair complexation of QACs with taurodeoxycholate (TDC), an endogenous anionic bile salt, on the apparent partition coefficients (APC) of QACs between n-octanol and phosphate buffer, and the inhibition of organic cation transporter1 (OCT1)- and P-glycoprotein (P-gp)-mediated transport of representative substrates.
RESULTS: By measuring the APC, we demonstrated that there is a Mw threshold of 200 +/- 50 in the ion-pair complexation of QACs with an endogenous bile salt, TDC. We also demonstrated, by measuring the inhibition of relevant transports, that a Mw threshold of 200 +/- 50 exists for the binding of QACs to canalicular P-gp, but not for sinusoidal OCT1. The Mw threshold values for ion-pair formation and P-gp binding were identical and consistent with the reported Mw threshold value for appreciable biliary excretion of QACs in rats.
CONCLUSIONS: Mw-dependent binding of QACs to canalicular P-gp contributes in part to the mechanism of the Mw threshold of 200 +/- 50. The formation of lipophilic ion-pair complexes with bile salts, followed by stronger binding to canalicular P-gp, appears to accelerate biliary excretion of QACs with a high Mw.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20221674     DOI: 10.1007/s11095-010-0075-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins.

Authors:  Guido J E J Hooiveld; Janette Heegsma; Jessica E van Montfoort; Peter L M Jansen; Dirk K F Meijer; Michael Müller
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

2.  Different activity of ATP dependent transport across the canalicular membrane for tributylmethylammonium and triethylmethylammonium as a potential mechanism of the preferential biliary excretion for tributylmethylammonium in the rat.

Authors:  I S Song; S J Chung; C K Shim
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

3.  Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.

Authors:  E J Wang; C N Casciano; R P Clement; W W Johnson
Journal:  Biochem Biophys Res Commun       Date:  2001-11-30       Impact factor: 3.575

4.  The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1.

Authors:  L Zhang; W Gorset; M J Dresser; K M Giacomini
Journal:  J Pharmacol Exp Ther       Date:  1999-03       Impact factor: 4.030

5.  Molecular weight as a factor in the excretion of monoquaternary ammonium cations in the bile of the rat, rabbit and guinea pig.

Authors:  R D Hughes; P Millburn; R T Williams
Journal:  Biochem J       Date:  1973-12       Impact factor: 3.857

6.  Contribution of ion-pair complexation with bile salts to the transport of organic cations across LLC-PK1 cell monolayers.

Authors:  Im-Sook Song; Yong-Hae Han; Suk-Jae Chung; Chang-Koo Shim
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

7.  Decreased biliary excretion of tributylmethyl ammonium in cholestyramine pretreated rats due to reduced formation of ion-pair complexes with hepatic bile salts.

Authors:  M K Choi; I S Song; D D Kim; S J Chung; C K Shim
Journal:  Biopharm Drug Dispos       Date:  2007-12       Impact factor: 1.627

8.  Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics.

Authors:  Yukio Kato; Seiko Takahara; Sayaka Kato; Yoshiyuki Kubo; Yoshimichi Sai; Ikumi Tamai; Hikaru Yabuuchi; Akira Tsuji
Journal:  Drug Metab Dispos       Date:  2008-03-13       Impact factor: 3.922

9.  Altered pharmacokinetics of daunorubicin in rats with CCl4-induced hepatic injury.

Authors:  Min-Koo Choi; Im-Sook Song; Dae-Duk Kim; Suk-Jae Chung; Chang-Koo Shim
Journal:  J Pharm Pharm Sci       Date:  2007       Impact factor: 2.327

10.  Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein.

Authors:  N Kusunoki; K Takara; Y Tanigawara; A Yamauchi; K Ueda; F Komada; Y Ku; Y Kuroda; Y Saitoh; K Okumura
Journal:  Jpn J Cancer Res       Date:  1998-11
View more
  1 in total

1.  Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).

Authors:  Manthena V Varma; Stefanus J Steyn; Charlotte Allerton; Ayman F El-Kattan
Journal:  Pharm Res       Date:  2015-07-09       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.